Neumora Therapeutics, Inc. (NMRA) vs VAXART, INC. (VXRT)
- Neumora Therapeutics, Inc. NMRA 0.48 0.00%
- VAXART, INC. VXRT 0.43 0.00%
Neumora Therapeutics, Inc. and VAXART, INC. are both Biotechnology companies. Neumora Therapeutics, Inc. and VAXART, INC. are of similar size ($92.4M and $90.2M). Neumora Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (15.9% vs 0.00%) and the higher return on invested capital (134.6% vs 0.00%). Across the 14 metrics below, VAXART, INC. leads on 13 and Neumora Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | NMRA | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 16.30% | 0.00% |
| Net margin | 0.00% | 15.88% | 0.00% |
| Free cash flow margin | 0.00% | 13.74% | 0.00% |
| Return on equity | (187.11%) | 66.97% | (56.66%) |
| Return on assets | (121.89%) | 23.44% | (49.22%) |
| Return on invested capital | 0.00% | 134.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack